Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Harefuah|November 15, 2023
[A MOLECULAR APPROACH TO DIAGNOSIS AND TREATMENT OF PEDIATRIC SOFT TISSUE SARCOMA FROM "E PLURIBUS UNUM" TO "EX UNO PLURES" AND BACK]Iris KventselPediatrics|December 13, 2016
Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case ReportUri Hamiel, Iris Kventsel, Ilan YoungsterClinical Toxicology (Philadelphia, Pa.)|January 31, 2006
Scopolamine treatment for severe extra-pyramidal signs following organophosphate (chlorpyrifos) ingestionIris Kventsel, Matitiahu Berkovitch, Ahuva Reiss, et al.Journal of Pediatric Hematology/Oncology|May 2, 2015
The Risk of Serious Bacterial Infection in Neutropenic Immunocompetent Febrile ChildrenAssaf A Barg, Eran Kozer, Yair Mordish, et al.The Oncologist|June 11, 2026
Women's Health Across the Reproductive Lifespan in Women with Germline TP53 Pathogenic Variants: A Clinical PerspectiveNaama Halpern, Rinat Bernstein-Molho, Yehudit Peerless, et al.Pediatric Blood & Cancer|September 23, 2023
Ocular venous occlusion in pediatrics: Should thrombophilia investigation and anticoagulant treatment be initiated?Marganit Benish, Shai Shrot, Assaf Barg, et al.Acta Oncologica (Stockholm, Sweden)|October 16, 2007
Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cellsGil Galanti, Tamar Fisher, Iris Kventsel, et al.Hemoglobin|September 16, 2014
Characterization of two unique α-globin gene cluster deletions causing α-thalassemia in Israeli ArabsOded Gilad, Orly Dgany, Sharon Noy-Lotan, et al.Familial Cancer|July 22, 2026
Clinical and surveillance outcomes of the TP53 c.1000G > C (p.Gly334Arg) variantYehudit Peerless, Rinat Bernstein-Molho, Iris Kventsel, et al.Cancer|June 21, 2025
Transmission ratio distortion of germline TP53 variants in Li-Fraumeni syndrome familiesNaama Halpern, Iris Kventsel, Gal Strauss, et al.Pageof 2